Picture of Exagen logo

XGN Exagen Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Exagen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-16.7-26.9-47.4-23.7-15.1
Depreciation
Deferred Taxes
Non-Cash Items3.55.5512.36.733.19
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.34-0.0611.670.325-3.08
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-14.1-20.3-32.1-14.5-13.3
Capital Expenditures-0.455-2.42-4.32-0.828-0.515
Purchase of Fixed Assets
Other Investing Cash Flow Items00.0240
Sale of Fixed Assets
Cash from Investing Activities-0.455-2.42-4.32-0.804-0.515
Financing Cash Flow Items-0.021-4.45-0.2390
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.09764.7-0.489-10.6-0.663
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-14.642-37-25.9-14.5